Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial

Double Blind ◽

Double Blind Placebo ◽

Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial

Diabetes & Metabolism ◽

10.1016/s1262-3636(07)70116-7 ◽

2004 ◽

Vol 30 (3) ◽

pp. 253-258 ◽

Cited By ~ 154

Author(s):

F Guerrero-Romero ◽

HE Tamez-Perez ◽

G González-González ◽

AM Salinas-Martínez ◽

J Montes-Villarreal ◽

...

Keyword(s):

Insulin Resistance ◽

Insulin Sensitivity ◽

Randomized Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial

Diabetes & Metabolism ◽

10.1016/j.diabet.2015.03.010 ◽

2015 ◽

Vol 41 (3) ◽

pp. 202-207 ◽

Cited By ~ 43

Author(s):

F. Guerrero-Romero ◽

L.E. Simental-Mendía ◽

G. Hernández-Ronquillo ◽

M. Rodriguez-Morán

Keyword(s):

Randomized Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial

Biological Trace Element Research ◽

10.1007/s12011-019-01687-6 ◽

2019 ◽

Vol 193 (1) ◽

pp. 23-35 ◽

Cited By ~ 5

Author(s):

Mehdi Sadeghian ◽

Leila Azadbakht ◽

Noushin Khalili ◽

Mojgan Mortazavi ◽

Ahmad Esmaillzadeh

Keyword(s):

Insulin Resistance ◽

Clinical Trial ◽

Diabetic Nephropathy ◽

Lipid Profile ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Double Blind ◽

Randomized Controlled ◽

Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial

Advances in Chronic Kidney Disease ◽

10.1053/j.ackd.2018.02.011 ◽

2018 ◽

Vol 25 (3) ◽

pp. 261-266 ◽

Cited By ~ 8

Author(s):

Martha Rodríguez-Morán ◽

Luis E. Simental-Mendía ◽

Claudia I. Gamboa-Gómez ◽

Fernando Guerrero-Romero

Keyword(s):

Metabolic Syndrome ◽

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Magnesium Supplementation Decreases C-reactive Protein Levels in Subjects with Prediabetes and Hypomagnesemia: A Clinical Randomized Double-blind Placebo-controlled Trial

Archives of Medical Research ◽

10.1016/j.arcmed.2014.04.006 ◽

2014 ◽

Vol 45 (4) ◽

pp. 325-330 ◽

Cited By ~ 30

Author(s):

Luis E. Simental-Mendía ◽

Martha Rodríguez-Morán ◽

Fernando Guerrero-Romero

Keyword(s):

Controlled Trial ◽

C Reactive Protein ◽

Double Blind ◽

Double Blind Placebo ◽

Protein Levels ◽

Reactive Protein ◽

Effect of oral magnesium supplementation on the transcription of TRPM6, TRPM7, and SLC41A1 in individuals newly diagnosed of pre-hypertension. A randomized, double-blind, placebo-controlled trial

Magnesium Research ◽

10.1684/mrh.2017.0426 ◽

2017 ◽

Vol 30 (3) ◽

pp. 80-87 ◽

Cited By ~ 7

Author(s):

Mariana Rodríguez-Ramírez ◽

Martha Rodríguez-Morán ◽

Miguel A. Reyes-Romero ◽

Fernando Guerrero-Romero

Keyword(s):

Controlled Trial ◽

Newly Diagnosed ◽

Double Blind ◽

Double Blind Placebo ◽

METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN

Endocrine Practice ◽

10.4158/ep151087.or ◽

2016 ◽

Vol 22 (5) ◽

pp. 575-586 ◽

Cited By ~ 3

Author(s):

Harriette Mogul ◽

Ruth Freeman ◽

Khoa Nguyen

Keyword(s):

Insulin Resistance ◽

Weight Loss ◽

Weight Gain ◽

Randomized Trial ◽

Metabolic Profile ◽

Fat Tissue ◽

Double Blind ◽

Double Blind Placebo ◽

Sustained Weight Loss ◽

Android Fat

Oral Magnesium Supplementation Improves the Metabolic Profile of Metabolically Obese, Normal-weight Individuals: A Randomized Double-blind Placebo-controlled Trial

Archives of Medical Research ◽

10.1016/j.arcmed.2014.05.003 ◽

2014 ◽

Vol 45 (5) ◽

pp. 388-393 ◽

Cited By ~ 37

Author(s):

Martha Rodríguez-Moran ◽

Fernando Guerrero-Romero

Keyword(s):

Metabolic Profile ◽

Controlled Trial ◽

Normal Weight ◽

Double Blind ◽

Double Blind Placebo ◽

Metabolically Obese Normal Weight ◽

Isosorbide monitrate with nadolol campared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double blind placebo controlled randomized trial. Final report

Journal of Hepatology ◽

10.1016/s0168-8278(01)80215-4 ◽

2001 ◽

Vol 34 (0) ◽

pp. 63 ◽

Cited By ~ 1

Author(s):

R Patti

Keyword(s):

Randomized Trial ◽

Recurrent Bleeding ◽

Final Report ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: a double-blind, placebo-controlled randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725397448.793533316 ◽

2017 ◽

Author(s):

Darin Correll

Keyword(s):

Chronic Pain ◽

Randomized Trial ◽

Double Blind ◽

Double Blind Placebo